{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:39:15Z","timestamp":1790912355208,"version":"4.1.0"},"reference-count":270,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Antioxidant activity is a normal physiological function that is essential for healthy living, and it is maintained by antioxidant dietary nutrients. However, increases in free radical production and oxidative toxicity in many clinical conditions can cause serious and sometimes irreversible damage. Despite many investigations, including hundreds of clinical trials suggesting that there are health benefits obtained from the use of natural antioxidants, no antioxidant drugs have yet been developed for the treatment of any disease associated with free radical pathology. Millions of people choose to use nutraceutical and natural product antioxidants as therapeutics and also for chemoprevention against cancer and other diseases. New academic efforts and strategies are required for the development of antioxidant drugs in clinical practice in the absence of interest by the pharmaceutical and nutraceutical industries. One of the most effective antioxidant therapeutic strategies is inhibition by chelators of iron involved in the catalytic formation of free radical reactions and their associated damage. Hundreds of phytochelators have been shown to inhibit oxidative damage, similar to the iron-chelating drugs deferiprone and deferoxamine. In particular, several nutraceuticals and natural products such as ascorbic acid, quercetin, curcumin, fisetin, lipoic acid, and maltol have been shown to have high antioxidant activity and iron-binding capacity, as well as other effects on iron metabolism, in pre-clinical studies and clinical trials involving different categories of patients. For example, ascorbic acid and maltol\u2013iron complexes are sold as pharmaceutical products for the treatment of iron deficiency. The development of nutraceuticals as antioxidant drugs may involve one or more applications, such as short- or long-term treatments, single-drug or combination therapies, and also different targets, such as the prevention, treatment, or post-treatment of diseases associated with free radical pathology as well as ferroptosis. The academic efforts surrounding the developments of iron-chelating nutraceuticals or natural products into antioxidant pharmaceuticals should fulfill all of the regulatory requirements and include clinical tests of antioxidants in rare or untreatable diseases, as well as the involvement of government translational research institutions and expert groups that specialize in regulatory drug affairs, among others.<\/jats:p>","DOI":"10.3390\/nu17203270","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:29:17Z","timestamp":1760711357000},"page":"3270","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of Iron-Chelating\/Antioxidant Nutraceuticals and Natural Products as Pharmaceuticals for Clinical Use in Diseases with Free Radical Pathologies"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-7340","authenticated-orcid":false,"given":"George J.","family":"Kontoghiorghes","sequence":"first","affiliation":[{"name":"Postgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol 3021, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Puri, V., Nagpal, M., Singh, I., Singh, M., Dhingra, G.A., Huanbutta, K., Dheer, D., Sharma, A., and Sangnim, T. (2022). A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges. Nutrients, 14.","DOI":"10.3390\/nu14214637"},{"key":"ref_2","first-page":"1487","article-title":"New concepts in nutraceuticals as alternative for pharmaceuticals","volume":"5","author":"Nasri","year":"2014","journal-title":"Int. J. Prev. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"AlAli, M., Alqubaisy, M., Aljaafari, M.N., AlAli, A.O., Baqais, L., Molouki, A., Abushelaibi, A., Lai, K.-S., and Lim, S.-H.E. (2021). Nutraceuticals: Transformation of Conventional Foods into Health Promoters\/Disease Preventers and Safety Considerations. Molecules, 26.","DOI":"10.3390\/molecules26092540"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Chandra, S., Saklani, S., Kumar, P., Kim, B., and Coutinho, H.D.M. (2022). Nutraceuticals: Pharmacologically Active Potent Dietary Supplements. Biomed. Res. Int., 2022.","DOI":"10.1155\/2022\/2051017"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2025). New Approaches and Strategies for the Repurposing of Iron Chelating\/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine. Antioxidants, 14.","DOI":"10.3390\/antiox14080982"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/13543784.2019.1631284","article-title":"Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology","volume":"28","author":"Kontoghiorghes","year":"2019","journal-title":"Expert. Opin. Investig. Drugs."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/jn\/nxac168","article-title":"Trends in Overall and Micronutrient-Containing Dietary Supplement Use in US Adults and Children, NHANES 2007\u20132018","volume":"152","author":"Cowan","year":"2022","journal-title":"J. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Imam, M.U., Zhang, S., Ma, J., Wang, H., and Wang, F. (2017). Antioxidants Mediate Both Iron Homeostasis and Oxidative Stress. Nutrients, 9.","DOI":"10.3390\/nu9070671"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/acs.chemrestox.1c00348","article-title":"Redox Activity of Flavonoids: Impact on Human Health, Therapeutics, and Chemical Safety","volume":"35","author":"Sarkar","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Reddy, V.P. (2023). Oxidative Stress in Health and Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11112925"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Iakovou, E., and Kourti, M. (2022). A Comprehensive Overview of the Complex Role of Oxidative Stress in Aging, The Contributing Environmental Stressors and Emerging Antioxidant Therapeutic Interventions. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.827900"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"26505","DOI":"10.1074\/jbc.R113.457564","article-title":"Regulation of circadian clocks by redox homeostasis","volume":"288","author":"Stangherlin","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.freeradbiomed.2016.07.003","article-title":"Redox signaling: An evolution from free radicals to aging","volume":"97","author":"Forman","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Su, Z., Hu, Q., Li, X., Wang, Z., and Xie, Y. (2024). The Influence of Circadian Rhythms on DNA Damage Repair in Skin Photoaging. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252010926"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Arevalo, J.A., and V\u00e1zquez-Medina, J.P. (2018). The Role of Peroxiredoxin 6 in Cell Signaling. Antioxidants, 7.","DOI":"10.3390\/antiox7120172"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"541230","DOI":"10.1155\/2014\/541230","article-title":"Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: Toward mitochondria-targeted clinical strategies","volume":"2014","author":"Pagano","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.3390\/ijms140612222","article-title":"UV radiation and the skin","volume":"14","author":"Jarrett","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1534735404270612","article-title":"Reassessment of a free radical theory of cancer with emphasis on ultraviolet carcinogenesis","volume":"3","author":"Black","year":"2004","journal-title":"Integr. Cancer Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.2174\/09298673113209990146","article-title":"Chemistry and pharmacological properties of some natural and synthetic antioxidants for heavy metal toxicity","volume":"20","author":"Flora","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.123.323617","article-title":"Heavy Metal Exposure and Cardiovascular Disease","volume":"134","author":"Pan","year":"2024","journal-title":"Circ. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/ijc.32048","article-title":"The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015","volume":"144","author":"Shield","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41420-024-02278-8","article-title":"Free radicals and their impact on health and antioxidant defenses: A review","volume":"11","author":"Chandimali","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_23","unstructured":"Denisov, E.T., and Afanas\u2019ev, I.B. (2005). Oxidation and Antioxidants in Organic Chemistry and Biology, CRC Press, Taylor and Francis Group."},{"key":"ref_24","first-page":"598","article-title":"Free radicals, antioxidants and human disease: Where are we now?","volume":"119","author":"Halliwell","year":"1992","journal-title":"J. Lab. Clin. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1007\/s00204-024-03850-y","article-title":"Unrevealing the mechanisms behind the cardioprotective effect of wheat polyphenolics","volume":"98","author":"Chakraborty","year":"2024","journal-title":"Arch. Toxicol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20841","DOI":"10.3390\/molecules201119725","article-title":"Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology","volume":"20","author":"Kontoghiorghe","year":"2015","journal-title":"Molecules"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Black, H.S., Boehm, F., Edge, R., and Truscott, T.G. (2020). The Benefits and Risks of Certain Dietary Carotenoids that Exhibit both Anti- and Pro-Oxidative Mechanisms-A Comprehensive Review. Antioxidants, 9.","DOI":"10.3390\/antiox9030264"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2891-9-3","article-title":"The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide","volume":"9","author":"Carlsen","year":"2010","journal-title":"Nutr. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/clinchem\/41.12.1819","article-title":"Lipid peroxidation and antioxidants as biomarkers of tissue damage","volume":"41","author":"Gutteridge","year":"1995","journal-title":"Clin. Chem."},{"key":"ref_30","first-page":"1","article-title":"Oxidative DNA damage and disease: Induction, repair and significance","volume":"567","author":"Evans","year":"2004","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00726-003-0011-2","article-title":"Free radical-mediated oxidation of free amino acids and amino acid residues in proteins","volume":"25","author":"Stadtman","year":"2003","journal-title":"Amino Acids"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"130524","DOI":"10.1016\/j.foodchem.2021.130524","article-title":"Free radical-mediated degradation of polysaccharides: Mechanism of free radical formation and degradation, influence factors and product properties","volume":"365","author":"Chen","year":"2021","journal-title":"Food Chem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Galaris, D., Barbouti, A., and Pantopoulos, K. (2019). Iron homeostasis and oxidative stress: An intimate relationship. Biochim. Biophys. Acta (BBA) Mol. Cell Res., 1866.","DOI":"10.1016\/j.bbamcr.2019.118535"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J., and Kontoghiorghe, C.N. (2020). Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells, 9.","DOI":"10.3390\/cells9061456"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1021\/bi300752r","article-title":"Mechanisms of mammalian iron homeostasis","volume":"51","author":"Pantopoulos","year":"2012","journal-title":"Biochemistry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: Process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/cmdc.202100334","article-title":"Autophagy-Dependent Ferroptosis as a Therapeutic Target in Cancer","volume":"16","author":"Liu","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: Opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Catapano, A., Cimmino, F., Petrella, L., Pizzella, A., D\u2019ANgelo, M., Ambrosio, K., Marino, F., Sabbatini, A., Petrelli, M., and Paolini, B. (2025). Iron metabolism and ferroptosis in health and diseases: The crucial role of mitochondria in metabolically active tissues. J. Nutr. Biochem., 140.","DOI":"10.1016\/j.jnutbio.2025.109888"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhong, M., Wang, Y., Min, J., and Wang, F. (2025). Iron metabolism and ferroptosis in human health and disease. BMC Biol., 23.","DOI":"10.1186\/s12915-025-02378-6"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/13543784.2013.787408","article-title":"Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals","volume":"22","author":"Kontoghiorghe","year":"2013","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0304-4165(86)90164-9","article-title":"Iron mobilisation from lactoferrin by chelators at physiological pH","volume":"882","author":"Kontoghiorghes","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kell, D.B., Heyden, E.L., and Pretorius, E. (2020). The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01221"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Arosio, P. (2022). New Advances in Iron Metabolism, Ferritin and Hepcidin Research. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314700"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2024). The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094654"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wouters, O.J., Denolle, C., Wei, J., and Papanicolas, I. (2025). Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets. JAMA Health Forum, 6.","DOI":"10.1001\/jamahealthforum.2025.2043"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5662\/wjm.v4.i3.163","article-title":"World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients","volume":"4","author":"Kontoghiorghe","year":"2014","journal-title":"World J. Methodol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2023). Drug Selection and Posology, Optimal Therapies and Risk\/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316749"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/DDDT.S79458","article-title":"Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes","volume":"10","author":"Kontoghiorghe","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(07)61197-0","article-title":"Red blood cell transfusion in clinical practice","volume":"370","author":"Klein","year":"2007","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/blood.2023022502","article-title":"Management of iron overload: Lessons from transfusion-dependent hemoglobinopathies","volume":"145","author":"Coates","year":"2025","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0098-2997(83)90004-3","article-title":"Iron overload","volume":"6","author":"Iancu","year":"1983","journal-title":"Mol. Asp. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","article-title":"Survival and causes of death in thalassaemia major","volume":"334","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in \u03b2-thalassaemia major in the UK: Data from the UK Thalassaemia Register","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3324\/haematol.2009.009118","article-title":"Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone","volume":"94","author":"Telfer","year":"2009","journal-title":"Haematologica"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/03630260903212043","article-title":"Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease. experience from a Cyprus model and its use as a paradigm for future applications","volume":"33","author":"Kolnagou","year":"2009","journal-title":"Hemoglobin"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bcmd.2011.07.002","article-title":"Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials","volume":"47","author":"Maggio","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_61","first-page":"261","article-title":"A synopsis of current care of thalassaemia major patients in Hong Kong","volume":"17","author":"Au","year":"2011","journal-title":"Hong Kong Med. J."},{"key":"ref_62","unstructured":"US Food and Drug Administration (2025, August 06). Clinical Review: Exjade (Deferasirox, ICL-670), Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/021882_s000_Exjade_BioPharmr.pdf."},{"key":"ref_63","unstructured":"(2015, December 01). Exjade (Deferasirox) Tablets for Oral Suspension [Prescribing Information], Available online: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021882s010lbl.pdf."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14740330903535845","article-title":"Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases","volume":"9","author":"Kontoghiorghes","year":"2010","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/nep.12523","article-title":"Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use","volume":"20","author":"Chuang","year":"2015","journal-title":"Nephrology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5001\/omj.2013.31","article-title":"Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia","volume":"28","author":"Bhandari","year":"2013","journal-title":"Oman Med. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"19543","DOI":"10.18632\/oncotarget.24646","article-title":"Total body irradiation and iron chelation treatment are associated with pancreatic injury following pediatric hematopoietic stem cell transplantation","volume":"9","author":"Maximova","year":"2018","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/TCRM.S170761","article-title":"What is known about deferasirox chelation therapy in pediatric HSCT recipients: Two case reports of metabolic acidosis","volume":"14","author":"Fucile","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0272-6386(12)80606-8","article-title":"Deferoxamine therapy and mucormycosis in dialysis patients: Report of an international registry","volume":"18","author":"Boelaert","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000186094","article-title":"Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine","volume":"56","author":"Cases","year":"1990","journal-title":"Nephron"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s004310050042","article-title":"Acute respiratory distress syndrome in children with acute iron poisoning: The role of intravenous desferrioxamine","volume":"159","author":"Ioannides","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2023). The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases. Pharmaceuticals, 16.","DOI":"10.3390\/ph16071016"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.taap.2017.11.005","article-title":"Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis","volume":"338","author":"Chan","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-642-74936-0_37","article-title":"Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice","volume":"14","author":"Eybl","year":"1991","journal-title":"Arch. Toxicol. Suppl."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0022-3565(25)38746-X","article-title":"The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats","volume":"269","author":"Sadrzadeh","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10715768609088062","article-title":"In vitro screening of iron chelators using models of free radical damage","volume":"2","author":"Kontoghiorghes","year":"1986","journal-title":"Free. Radic. Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Seddiek, H., Hanna, M., Hamoud, A.E.M., Elbaset, M.A., Akabawy, A.M.A., Kotb, M.Z., and Khalifa, M.M. (2025). Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-87628-x"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2002-10-3280","article-title":"Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone","volume":"102","author":"Cohen","year":"2003","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2141.2002.03554.x","article-title":"The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients","volume":"118","author":"Ceci","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_80","first-page":"795","article-title":"Deferiprone in the treatment of transfusion-dependent thalassemia: A review and perspective","volume":"3","author":"Galanello","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_81","first-page":"496","article-title":"Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemia","volume":"83","author":"Mazza","year":"1998","journal-title":"Haematologica"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ajh.24024","article-title":"Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial","volume":"90","author":"Calvaruso","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_83","first-page":"929","article-title":"L1 arthropathy syndrome","volume":"42","author":"Agarwal","year":"1994","journal-title":"J. Assoc. Physicians India"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Kolnagou, A., Kleanthous, M., and Kontoghiorghes, G.J. (2022). Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease. Front. Biosci., 14.","DOI":"10.31083\/j.fbe1403018"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/13880209.2014.923000","article-title":"Efficacy behind activity-phytotherapeutics are not different from pharmaceuticals","volume":"53","author":"Varoni","year":"2015","journal-title":"Pharm. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtemb.2014.11.005","article-title":"Effect of phytic acid, tannic acid and pectin on fasting iron bioavailability both in the presence and absence of calcium","volume":"30","author":"Jaramillo","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12013-009-9043-x","article-title":"A review of the antioxidant mechanisms of polyphenol compounds related to iron binding","volume":"53","author":"Perron","year":"2009","journal-title":"Cell Biochem. Biophys."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0006-2952(01)00821-8","article-title":"Iron complexes of deferiprone and dietary plant catechols as cytoprotective superoxide radical scavengers","volume":"62","author":"Moridani","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(08)60983-7","article-title":"Antioxidant and chelating properties of flavonoids","volume":"38","author":"Korkina","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1039\/C4FO00007B","article-title":"Reactivity of food phenols with iron and copper ions: Binding, dioxygen activation and oxidation mechanisms","volume":"5","author":"Nkhili","year":"2014","journal-title":"Food Funct."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients with Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13054-017-1891-y","article-title":"Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes","volume":"21","author":"Carr","year":"2017","journal-title":"Crit. Care"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcrc.2018.07.004","article-title":"Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: Propensity score-based analysis of a before-after cohort study","volume":"47","author":"Kim","year":"2018","journal-title":"J. Crit. Care"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1158\/1078-0432.CCR-06-1812","article-title":"A phase I\/II study of arsenic trioxide\/bortezomib\/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma","volume":"13","author":"Berenson","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J., Kolnagou, A., Kontoghiorghe, C.N., Mourouzidis, L., Timoshnikov, V.A., and Polyakov, N.E. (2020). Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications. Medicines, 7.","DOI":"10.3390\/medicines7080045"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10534-008-9137-8","article-title":"Investigation of ascorbate-mediated iron release from ferric phytosiderophores in the presence of nicotianamine","volume":"21","author":"Weber","year":"2008","journal-title":"Biometals"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2125.1991.tb05525.x","article-title":"Iron supplements: A common cause of drug interactions","volume":"31","author":"Campbell","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1750-3841.2010.01796.x","article-title":"Dietary ligands as determinants of iron-zinc interactions at the absorptive enterocyte","volume":"75","author":"Iyengar","year":"2010","journal-title":"J. Food Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3945\/jn.110.125369","article-title":"Polyphenols and phytic acid contribute to the low iron bioavailability from common beans in young women","volume":"140","author":"Petry","year":"2010","journal-title":"J. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Timoshnikov, V.A., Kobzeva, T.V., Polyakov, N.E., and Kontoghiorghes, G.J. (2020). Redox Interactions of Vitamin C and Iron: Inhibition of the Pro-Oxidant Activity by Deferiprone. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113967"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2307\/3579271","article-title":"Catalytic Metals, Ascorbate and Free Radicals: Combinations to Avoid","volume":"145","author":"Buettner","year":"1996","journal-title":"Radiat. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.ccr.2006.03.002","article-title":"The coordination chemistry of Vitamin C: An overview","volume":"250","year":"2006","journal-title":"Coord. Chem. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Macan, A.M., Kraljevi\u0107, T.G., and Rai\u0107-Mali\u0107, S. (2019). Therapeutic perspective of vitamin C and its derivatives. Antioxidants, 8.","DOI":"10.3390\/antiox8080247"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2891-2-7","article-title":"Vitamin C in human health and disease is still a mystery? An overview","volume":"2","author":"Naidu","year":"2003","journal-title":"Nutr. J."},{"key":"ref_105","first-page":"403","article-title":"Correction of anemia and iron deficiency in vegetarians by administration of ascorbic acid","volume":"39","author":"Sharma","year":"1995","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Marik, P.E. (2018). Hydrocortisone, ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. focus on ascorbic acid. Nutrients, 10.","DOI":"10.20944\/preprints201810.0285.v1"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jama.2019.21984","article-title":"Vitamin C for Sepsis and Acute Respiratory Failure","volume":"323","author":"Hager","year":"2020","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Talib, W.H., Sabri, S.M., Hadi, R.W., Pr\u00e9musz, V., and Beregi, T. (2025). Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies. Nutrients, 17.","DOI":"10.3390\/nu17193120"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Loft, F.C., Holse, C., Aasvang, E.K., Vester-Andersen, M., Rasmussen, L.S., J\u00f8rgensen, L.N., and Meyhoff, C.S. (2025). Effects of Hyperoxia and Antioxidants on Mortality, Hospital Admissions, and Myocardial Infarction After Noncardiac Surgery: 1-Year Follow-Up of a Randomized Controlled Trial. Acta Anaesthesiol. Scand., 69.","DOI":"10.1111\/aas.70118"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1345\/aph.1G280","article-title":"Dementia and Alzheimer\u2019s disease in community-dwelling elders taking vitamin C and\/or vitamin E","volume":"39","author":"Fillenbaum","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1161\/01.CIR.99.25.3234","article-title":"Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease","volume":"99","author":"Gokce","year":"1999","journal-title":"Circulation"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00768.2005","article-title":"High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance","volume":"290","author":"Chen","year":"2006","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13054-020-02851-4","article-title":"A new clinical trial to test high-dose vitamin C in patients with COVID-19","volume":"24","author":"Carr","year":"2020","journal-title":"Crit. Care"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Van Gorkom, G.N.Y., Lookermans, E.L., Van Elssen, C.H.M.J., and Bos, G.M.J. (2019). The effect of vitamin C (Ascorbic acid) in the treatment of patients with cancer: A systematic review. Nutrients, 11.","DOI":"10.3390\/nu11050977"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Borst, P. (2008). Mega-dose vitamin C as therapy for human cancer?. Proc. Natl. Acad. Sci. USA, 105.","DOI":"10.1073\/pnas.0809328105"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1503\/cmaj.050346","article-title":"Intravenously administered vitamin C as cancer therapy: Three cases","volume":"174","author":"Padayatty","year":"2006","journal-title":"Can. Med. Assoc. J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1503\/cmaj.060228","article-title":"High-dose vitamin C therapy: Renewed hope or false promise?","volume":"174","author":"Assouline","year":"2006","journal-title":"Can. Med. Assoc. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1479-5876-10-189","article-title":"Effect of high-dose intravenous vitamin C on inflammation in cancer patients","volume":"10","author":"Mikirova","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3945\/ajcn.114.085480","article-title":"Vitamin E and C supplementation and risk of cancer in men: Posttrial follow-up in the Physicians\u2019 Health Study II randomized trial","volume":"100","author":"Wang","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/01635581.2013.806672","article-title":"Dietary antioxidants and prostate cancer: A review","volume":"65","author":"Vance","year":"2013","journal-title":"Nutr. Cancer"},{"key":"ref_121","first-page":"809","article-title":"High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer","volume":"29","author":"Ohno","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bcpt.12323","article-title":"Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: A pharmacokinetic evaluation","volume":"116","author":"Nielsen","year":"2015","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.93.8.3704","article-title":"Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance","volume":"93","author":"Levine","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1079\/BJN20061817","article-title":"Skin bioavailability of dietary vitamin E, carotenoids, polyphenols, vitamin C, zinc and selenium","volume":"96","author":"Myriam","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1749-6632.1980.tb21325.x","article-title":"Interaction of vitamin C and iron","volume":"355","author":"Lynch","year":"1980","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12253-018-0539-9","article-title":"The Interrelationship of Pharmacologic Ascorbate Induced Cell Death and Ferroptosis","volume":"25","author":"Holczer","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2021.02.126","article-title":"Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activation","volume":"551","author":"Wang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2022.06.011","article-title":"Exogenous iron impairs the anti-cancer effect of ascorbic acid both in vitro and in vivo","volume":"46","author":"Zhong","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Vaishampayan, P., and Lee, Y. (2024). Redox-active vitamin C suppresses human osteosarcoma growth by triggering intracellular ROS-iron-calcium signaling crosstalk and mitochondrial dysfunction. Redox Biol., 75.","DOI":"10.1016\/j.redox.2024.103288"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Montero, J., Chichiarelli, S., Eufemi, M., Altieri, F., Saso, L., and Rodrigo, R. (2022). Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back. Molecules, 27.","DOI":"10.3390\/molecules27123818"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s12098-019-03068-2","article-title":"Comparison of Therapeutic Efficacy of Ferrous Ascorbate and Iron Polymaltose Complex in Iron Deficiency Anemia in Children: A Randomized Controlled Trial","volume":"86","author":"Patil","year":"2019","journal-title":"Indian J. Pediatr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12098-019-03107-y","article-title":"Treating Iron Deficiency Anemia","volume":"86","author":"Chandra","year":"2019","journal-title":"Indian J. Pediatr."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/ped.14237","article-title":"Ferrous Sulfate Oral Solution in Young Children with Iron Deficiency Anemia","volume":"62","author":"Kubiak","year":"2020","journal-title":"Pediatr. Int."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0950-3536(89)80020-4","article-title":"Desferrioxamine-induced iron excretion in humans","volume":"2","author":"Pippard","year":"1989","journal-title":"Baillieres Clin. Haematol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(77)92279-6","article-title":"Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine","volume":"1","author":"Hussain","year":"1977","journal-title":"Lancet"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/bmj.295.6612.1509","article-title":"Effective chelation of iron in \u03b2 thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one","volume":"295","author":"Kontoghiorghes","year":"1987","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/ejh.12594","article-title":"Role of vitamin C as an adjuvant therapy to different iron chelators in young \u03b2-thalassemia major patients: Efficacy and safety in relation to tissue iron overload","volume":"96","author":"Elalfy","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000206370","article-title":"Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis","volume":"72","author":"Conte","year":"1984","journal-title":"Acta Haematol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2013.2107","article-title":"Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: The TACT randomized trial","volume":"309","author":"Lamas","year":"2013","journal-title":"JAMA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2014.02.012","article-title":"EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy","volume":"168","author":"Lamas","year":"2014","journal-title":"Am. Hear. J."},{"key":"ref_141","first-page":"1332","article-title":"Chelators affecting iron absorption in mice","volume":"40","author":"Kontoghiorghes","year":"1990","journal-title":"Arzneim.-Forsch. Drug Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.freeradbiomed.2005.02.016","article-title":"Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy","volume":"38","author":"Hininger","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_143","first-page":"379","article-title":"Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte","volume":"3","author":"Mostert","year":"1987","journal-title":"Free Radic. Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"134668","DOI":"10.1016\/j.foodchem.2022.134668","article-title":"The effectiveness of dietary polyphenols in obesity management: A systematic review and meta-analysis of human clinical trials","volume":"404","author":"Zhang","year":"2023","journal-title":"Food Chem."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Sweeney, M., Burns, G., Sturgeon, N., Mears, K., Stote, K., and Blanton, C. (2022). The Effects of Berry Polyphenols on the Gut Microbiota and Blood Pressure: A Systematic Review of Randomized Clinical Trials in Humans. Nutrients, 14.","DOI":"10.3390\/nu14112263"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"S479","DOI":"10.3233\/JAD-231222","article-title":"Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer\u2019s Disease: Findings from Clinical Trials","volume":"101","author":"Chen","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/09546634.2014.991675","article-title":"Polyphenols as novel treatment options for dermatological diseases: A systematic review of clinical trials","volume":"26","author":"Tuong","year":"2015","journal-title":"J. Dermatol. Treat."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Georgiou, N., Kakava, M.G., Routsi, E.A., Petsas, E., Stavridis, N., Freris, C., Zoupanou, N., Moschovou, K., Kiriakidi, S., and Mavromoustakos, T. (2023). Quercetin: A Potential Polydynamic Drug. Molecules, 28.","DOI":"10.3390\/molecules28248141"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/0113894501292466240627050638","article-title":"Quercetin in Oncology: A Phytochemical with Immense Therapeutic Potential","volume":"25","author":"Kamal","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00614022","article-title":"Disposition of quercetin in man after single oral and intravenous doses","volume":"9","author":"Gugler","year":"1975","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.freeradbiomed.2004.01.001","article-title":"Flavonoids: Antioxidants or signalling molecules?","volume":"36","author":"Williams","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1039\/c1fo10025d","article-title":"The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems","volume":"2","author":"Barnes","year":"2011","journal-title":"Food Funct."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"105160","DOI":"10.1016\/j.chemphyslip.2021.105160","article-title":"Quercetin induces lipid domain-dependent permeability","volume":"242","author":"Leite","year":"2022","journal-title":"Chem. Phys. Lipids"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.3390\/molecules20058583","article-title":"Studies on transition metal-quercetin complexes using electrospray ionization tandem mass spectrometry","volume":"20","author":"Liu","year":"2015","journal-title":"Molecules"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12640-019-00142-7","article-title":"Synthesis of Quercetin-Metal Complexes, In Vitro and In Silico Anticholinesterase and Antioxidant Evaluation, and In Vivo Toxicological and Anxiolitic Activities","volume":"37","author":"Alves","year":"2020","journal-title":"Neurotox. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"6178261","DOI":"10.1155\/2022\/6178261","article-title":"Quercetin Zinc and Iron Metal Complexes Protect against Sodium Arsenite Intoxication in the Hepato-Renal System of Wistar Rats via the Oxidative Stress Pathway","volume":"2022","author":"Ojo","year":"2022","journal-title":"J. Toxicol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Bardestani, A., Ebrahimpour, S., Esmaeili, A., and Esmaeili, A. (2021). Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles. J. Nanobiotechnology, 19.","DOI":"10.1186\/s12951-021-01059-0"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Malacaria, L., Corrente, G.A., Beneduci, A., Furia, E., Marino, T., and Mazzone, G. (2021). A Review on Coordination Properties of Al(III) and Fe(III) toward Natural Antioxidant Molecules: Experimental and Theoretical Insights. Molecules, 26.","DOI":"10.3390\/molecules26092603"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.foodchem.2013.09.080","article-title":"Antioxidant study of quercetin and their metal complex and determination of stability constant by spectrophotometry method","volume":"146","author":"Ravichandran","year":"2014","journal-title":"Food Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00289-022-04091-8","article-title":"An insight into anticancer, antioxidant, antimicrobial, antidiabetic and anti-inflammatory effects of quercetin: A review","volume":"80","author":"Azeem","year":"2023","journal-title":"Polym. Bull."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/10715760500484351","article-title":"Interactions of quercetin with iron and copper ions: Complexation and autoxidation","volume":"40","author":"Nkhili","year":"2006","journal-title":"Free. Radic. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jn\/137.11.2405","article-title":"Quercetin reduces blood pressure in hypertensive subjects","volume":"137","author":"Edwards","year":"2007","journal-title":"J. Nutr."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/S0007114509359127","article-title":"Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study","volume":"102","author":"Egert","year":"2009","journal-title":"Br. J. Nutr."},{"key":"ref_164","first-page":"68","article-title":"Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study","volume":"76","author":"Kozhukhov","year":"2024","journal-title":"Hell. J. Cardiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clnesp.2023.04.019","article-title":"Effects of quercetin supplementation on endothelial dysfunction biomarkers and depression in post-myocardial infarction patients: A double-blind, placebo-controlled, randomized clinical trial","volume":"56","author":"Dehghani","year":"2023","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Papakyriakopoulou, P., Velidakis, N., Khattab, E., Valsami, G., Korakianitis, I., and Kadoglou, N.P. (2022). Potential Pharmaceutical Applications of Quercetin in Cardiovascular Diseases. Pharmaceuticals, 15.","DOI":"10.3390\/ph15081019"},{"key":"ref_167","first-page":"1414","article-title":"Therapeutic Potential of Quercetin as an Antioxidant for Bone-Muscle-Tendon Regeneration and Aging","volume":"16","author":"Kim","year":"2024","journal-title":"Aging Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/s41591-024-03096-2","article-title":"Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: A phase 2 randomized controlled trial","volume":"30","author":"Farr","year":"2024","journal-title":"Nat. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00774-025-01592-0","article-title":"Quercetins efficacy on bone and inflammatory markers, body composition, and physical function in postmenopausal women","volume":"43","author":"Bailly","year":"2025","journal-title":"J. Bone Miner. Metab."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Vaez, S., Parivr, K., Amidi, F., Rudbari, N.H., Moini, A., and Amini, N. (2023). Quercetin and polycystic ovary syndrome; inflammation, hormonal parameters and pregnancy outcome: A randomized clinical trial. Am. J. Reprod. Immunol., 89.","DOI":"10.1111\/aji.13644"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.tjnut.2024.04.025","article-title":"Higher Dietary Quercetin Intake Is Associated with Lower Risk of Adverse Outcomes among Individuals with Inflammatory Bowel Disease in a Prospective Cohort Study","volume":"154","author":"Wang","year":"2024","journal-title":"J. Nutr."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ajcnut.2024.07.013","article-title":"Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled crossover clinical trial","volume":"120","author":"Li","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1002\/ptr.8238","article-title":"The therapeutic potential of typical plant-derived compounds for the management of metabolic disorders","volume":"38","author":"Roy","year":"2024","journal-title":"Phytother. Res."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Han, M.K., Barreto, T.A., Martinez, F.J., Comstock, A.T., and Sajjan, U.S. (2020). Randomised clinical trial to determine the safety of supplementation in patients with chronic obstructive pulmonary disease. BMJ Open Respir. Res., 7.","DOI":"10.1136\/bmjresp-2018-000392"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Qi, W., Qi, W., Xiong, D., and Long, M. (2022). Quercetin: Its Antioxidant Mechanism, Antibacterial Properties and Potential Application in Prevention and Control of Toxipathy. Molecules, 27.","DOI":"10.3390\/molecules27196545"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/ptr.8117","article-title":"Potential use of quercetin in the reduction of craving in cocaine-dependent patients-A pilot clinical trial","volume":"38","author":"Nicolucci","year":"2024","journal-title":"Phytother. Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"111591","DOI":"10.1016\/j.mad.2021.111591","article-title":"Strategies for late phase preclinical and early clinical trials of senolytics","volume":"200","author":"Misra","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ctim.2019.02.017","article-title":"The effect of quercetin on iron overload and inflammation in \u03b2-thalassemia major patients: A double-blind randomized clinical trial","volume":"46","author":"Azarkeivan","year":"2019","journal-title":"Complement. Ther. Med."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Zhou, P., Yu, X., Song, T., and Hou, X. (2024). Safety and efficacy of antioxidant therapy in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0296926"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2017.10.001","article-title":"The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin","volume":"336","author":"Veith","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"106766","DOI":"10.1016\/j.ejps.2024.106766","article-title":"Curcumin and quercetin co-encapsulated in nanoemulsions for nasal administration: A promising therapeutic and prophylactic treatment for viral respiratory infections","volume":"197","author":"Vaiss","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ptr.7699","article-title":"Quercetin as a cancer chemopreventive or chemotherapeutic agent: Where we stand","volume":"37","author":"Boretti","year":"2023","journal-title":"Phytother. Res."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Zhang, H., Shi, H., Li, X., Zhou, S., Song, X., Ma, N., Meng, M., Chang, G., and Shen, X. (2025). Quercetin alleviates LPS\/iE-DAP-induced liver injury by suppressing ferroptosis via regulating ferritinophagy and intracellular iron efflux. Redox. Biol., 81.","DOI":"10.1016\/j.redox.2025.103557"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"114152","DOI":"10.1016\/j.intimp.2025.114152","article-title":"Quercetin inhibits oligodendrocytes ferroptosis by blocking NCOA4-mediated ferritinophagy","volume":"150","author":"Xiong","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Cruz-Gregorio, A., and Aranda-Rivera, A.K. (2023). Quercetin and Ferroptosis. Life, 13.","DOI":"10.3390\/life13081730"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jare.2020.07.007","article-title":"Quercetin alleviates acute kidney injury by inhibiting ferroptosis","volume":"28","author":"Wang","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"154887","DOI":"10.1016\/j.phymed.2023.154887","article-title":"Quercetin: A promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis","volume":"126","author":"Cheng","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","article-title":"The therapeutic potential of curcumin: A review of clinical trials","volume":"163","author":"Salehi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/acsptsci.2c00012","article-title":"Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials","volume":"6","author":"Kunnumakkara","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"156144","DOI":"10.1016\/j.cyto.2023.156144","article-title":"Antioxidant and anti-inflammatory effects of curcumin\/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials","volume":"164","author":"Dehzad","year":"2023","journal-title":"Cytokine"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Funk, J.L., and Schneider, C. (2021). Perspective on Improving the Relevance, Rigor, and Reproducibility of Botanical Clinical Trials: Lessons Learned From Turmeric Trials. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.782912"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Panknin, T.M., Howe, C.L., Hauer, M., Bucchireddigari, B., Rossi, A.M., and Funk, J.L. (2023). Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054476"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: Lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/nutraceuticals4040031","article-title":"Potential Applications of the Anti-Inflammatory, Antithrombotic and Antioxidant Health-Promoting Properties of Curcumin: A Critical Review","volume":"4","author":"Rapti","year":"2024","journal-title":"Nutraceuticals"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","article-title":"Antioxidant and anti-inflammatory properties of curcumin","volume":"595","author":"Menon","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Hewlings, S.J., and Kalman, D.S. (2017). Curcumin: A Review of Its Effects on Human Health. Foods, 6.","DOI":"10.3390\/foods6100092"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1517\/17425255.2011.570332","article-title":"The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs","volume":"7","author":"Han","year":"2011","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1002\/fsn3.1930","article-title":"Highly bioavailable curcumin preparation with a co-grinding and solvent-free process","volume":"8","author":"Lu","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Prasad, S., DuBourdieu, D., Srivastava, A., Kumar, P., and Lall, R. (2021). Metal-Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137094"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2017.10.022","article-title":"Metal chelating ability and antioxidant properties of Curcumin-metal complexes\u2014A DFT approach","volume":"79","author":"Mary","year":"2018","journal-title":"J. Mol. Graph. Model."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Smirnova, E., Moniruzzaman, M., Chin, S., Sureshbabu, A., Karthikeyan, A., Do, K., and Min, T. (2023). A Review of the Role of Curcumin in Metal Induced Toxicity. Antioxidants, 12.","DOI":"10.3390\/antiox12020243"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41420-019-0234-y","article-title":"Iron chelation by curcumin suppresses both curcumin-induced autophagy and cell death together with iron overload neoplastic transformation","volume":"5","author":"Rainey","year":"2019","journal-title":"Cell Death Discov."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Liu, Q., Sun, M., Wang, T., Zhou, Y., Sun, M., Li, H., Liu, Y., and Xu, A. (2023). The Differential Antagonistic Ability of Curcumin against Cytotoxicity and Genotoxicity Induced by Distinct Heavy Metals. Toxics, 11.","DOI":"10.3390\/toxics11030233"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Smith, T.J., and Ashar, B.H. (2019). Iron Deficiency Anemia Due to High-dose Turmeric. Cureus, 11.","DOI":"10.7759\/cureus.3858"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.redox.2014.01.018","article-title":"Curcumin may impair iron status when fed to mice for six months","volume":"2","author":"Chin","year":"2014","journal-title":"Redox Biol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7754\/Clin.Lab.2021.210629","article-title":"The Effect of Curcumin on Iron Overload in Patients with Beta-Thalassemia Intermedia","volume":"68","author":"Saeidnia","year":"2022","journal-title":"Clin. Lab."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Eghbali, A., Nourigheimasi, S., Ghasemi, A., Afzal, R.R., Ashayeri, N., Eghbali, A., Khanzadeh, S., and Ghaffari, K. (2023). The effects of curcumin on hepatic T2*MRI and liver enzymes in patients with \u03b2-thalassemia major: A double-blind randomized controlled clinical trial. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1284326"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000479634","article-title":"Benefits of Curcumin Supplementation on Antioxidant Status in \u03b2-Thalassemia Major Patients: A Double-Blind Randomized Controlled Clinical Trial","volume":"71","author":"Nasseri","year":"2017","journal-title":"Ann. Nutr. Metab."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Kose, T., Sharp, P.A., and Latunde-Dada, G.O. (2025). Antioxidative Effects of Curcumin on Erastin-Induced Ferroptosis Through GPX4 Signalling. Gastrointest. Disord., 7.","DOI":"10.3390\/gidisord7010004"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Yin, X., Hou, X., and Feng, J. (2025). Role of Ferroptosis on Lung Epithelial Cells in Disease Progression and Treatment: A Review. Med. Sci. Monit., 31.","DOI":"10.12659\/MSM.948226"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1759-7714.13904","article-title":"Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy","volume":"12","author":"Tang","year":"2021","journal-title":"Thorac. Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.7150\/ijbs.90798","article-title":"Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis","volume":"20","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Abah, M.O., Ogenyi, D.O., Zhilenkova, A.V., Essogmo, F.E., Uchendu, I.K., Tchawe, Y.S.N., Pascal, A.M., Nikitina, N.M., Oloche, O.S., and Pavliv, M. (2025). Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136161"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J., Kolnagou, A., Demetriou, T., Neocleous, M., and Kontoghiorghe, C.N. (2021). New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115546"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2023). Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054970"},{"key":"ref_218","unstructured":"Kontoghiorghes, G.J. (1982). The Design of Orally Active Iron Chelators for the Treatment of Thalassaemia. [Ph.D. Thesis, University of Essex]. Available online: https:\/\/www.pri.ac.cy\/files\/KGJ_thesis_1982.pdf."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/jnr.21397","article-title":"A novel compound, maltolyl p-coumarate, attenuates cognitive deficits and shows neuroprotective effects in vitro and in vivo dementia models","volume":"85","author":"Shin","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1016\/j.apsb.2024.05.025","article-title":"Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment","volume":"14","author":"Kao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s40242-021-1438-2","article-title":"Maltol as a Novel Agent Protecting SH-SY5Y Cells Against Hemin-induced Ferroptosis","volume":"38","author":"Hua","year":"2022","journal-title":"Chem. Res. Chin. Univ."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.023","article-title":"The flavonoid fisetin promotes nerve cell survival from trophic factor withdrawal by enhancement of proteasome activity","volume":"476","author":"Maher","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Ozdemir, S.A., Faizan, M.I., Kaur, G., Shaikh, S.B., Ul Islam, K., and Rahman, I. (2025). Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202508.1331.v1"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2174\/0113892010304479240415074928","article-title":"Fisetin from Dietary Supplement to a Drug Candidate: An Assessment of Potential","volume":"26","author":"Mirza","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.13141","article-title":"Senolytic drugs: From discovery to translation","volume":"288","author":"Kirkland","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1076029619871359","DOI":"10.1177\/1076029619871359","article-title":"Fisetin Prolongs Therapy Window of Brain Ischemic Stroke Using Tissue Plasminogen Activator: A Double-Blind Randomized Placebo-Controlled Clinical Trial","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Siewe, N., and Friedman, A. (2025). Modeling treatment of osteoarthritis with standard therapy and senolytic drugs. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0332763"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"111995","DOI":"10.1016\/j.mad.2024.111995","article-title":"Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases","volume":"222","author":"Tavenier","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/stmcls\/sxad036","article-title":"Fisetin Attenuates Cellular Senescence Accumulation During Culture Expansion of Human Adipose-Derived Stem Cells","volume":"41","author":"Mullen","year":"2023","journal-title":"Stem Cells"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Maher, P. (2020). Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper. Antioxidants, 9.","DOI":"10.3390\/antiox9111113"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1039\/c0dt01834a","article-title":"Comparative spectroscopic and mechanistic study of chelation properties of fisetin with iron in aqueous buffered solutions. Implications on in vitro antioxidant activity","volume":"40","year":"2011","journal-title":"Dalton Trans."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.freeradbiomed.2007.10.050","article-title":"Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity","volume":"44","author":"Triantafyllou","year":"2008","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","article-title":"Management of oxidative stress and other pathologies in Alzheimer\u2019s disease","volume":"93","author":"Simunkova","year":"2019","journal-title":"Arch. Toxicol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0891-5849(99)00167-7","article-title":"Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid","volume":"27","author":"Sugihara","year":"1999","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Yang, H., Hong, Y., Gong, M., Cai, S., Yuan, Z., Feng, S., Chen, Q., Liu, X., and Mei, Z. (2024). Fisetin exerts neuroprotective effects in vivo and in vitro by inhibiting ferroptosis and oxidative stress after traumatic brain injury. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1480345"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Li, D., Liu, X., Pi, W., Zhang, Y., Yu, L., Xu, C., Sun, Z., and Jiang, J. (2022). Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1\/Nrf2 Signaling Pathway Activation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.808480"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Goujon, M., Liang, Z., Soriano-Castell, D., Currais, A., and Maher, P. (2024). The Neuroprotective Flavonoids Sterubin and Fisetin Maintain Mitochondrial Health under Oxytotic\/Ferroptotic Stress and Improve Bioenergetic Efficiency in HT22 Neuronal Cells. Antioxidants, 13.","DOI":"10.3390\/antiox13040460"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"176298","DOI":"10.1016\/j.ejphar.2023.176298","article-title":"Fisetin suppresses ferroptosis through Nrf2 and attenuates intervertebral disc degeneration in rats","volume":"964","author":"Li","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000538535","article-title":"Fisetin Suppresses Atherosclerosis by Inhibiting Ferroptosis-Related Oxidative Stress in Apolipoprotein E Knockout Mice","volume":"109","author":"Jiang","year":"2024","journal-title":"Pharmacology"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Szymczak, J., and Cielecka-Piontek, J. (2023). Fisetin-In Search of Better Bioavailability-From Macro to Nano Modifications: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814158"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.jrn.2024.08.004","article-title":"Effects of Alpha-Lipoic Acid Supplementation on Weight Loss, Inflammatory, Lipid, and Hematological Levels in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"35","author":"Rezaei","year":"2024","journal-title":"J. Ren. Nutr."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"e088363","DOI":"10.1136\/bmjopen-2024-088363","article-title":"Alpha-lipoic acid on intermediate disease markers in overweight or obese adults: A systematic review and meta-analysis","volume":"15","author":"Luo","year":"2025","journal-title":"BMJ Open"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.2174\/0929867329666221006115329","article-title":"Potential for Novel Therapeutic Uses of Alpha Lipoic Acid","volume":"30","author":"Fasipe","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.expneurol.2008.08.013","article-title":"Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy","volume":"214","author":"Melli","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_246","first-page":"2313","article-title":"Alpha-lipoic acid improved anemia, erythropoietin resistance, maintained glycemic control, and reduced cardiovascular risk in diabetic patients on hemodialysis: A multi-center prospective randomized controlled study","volume":"26","author":"Nienaa","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.trsl.2020.08.009","article-title":"Friedreich Ataxia: Current state-of-the-art, and future prospects for mitochondrial-focused therapies","volume":"229","author":"Pagano","year":"2021","journal-title":"Transl. Res."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Camiolo, G., Tibullo, D., Giallongo, C., Romano, A., Parrinello, N.L., Musumeci, G., Di Rosa, M., Vicario, N., Brundo, M.V., and Amenta, F. (2019). \u03b1-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030609"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"36623","DOI":"10.31083\/IJVNR36623","article-title":"Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials","volume":"95","author":"Abdollahzad","year":"2024","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1179\/135100005X21624","article-title":"Dietary supplementation with (R)-\u03b1-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex","volume":"10","author":"Suh","year":"2005","journal-title":"Redox Rep."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Tai, S., Zheng, Q., Zhai, S., Cai, T., Xu, L., Yang, L., Jiao, L., and Zhang, C. (2020). Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson\u2019s Disease Model Induced by 6-OHDA. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00612"},{"key":"ref_252","first-page":"883","article-title":"Effect of alpha lipoic acid on the blood cell count iron kinetics, in hypertensive patients","volume":"31","author":"Mendes","year":"2014","journal-title":"Nutr. Hosp."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1734-1140(11)70600-4","article-title":"Lipoic acid\u2014Biological activity and therapeutic potential","volume":"63","author":"Piechota","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Cho, S., Hong, S.J., Kang, S.H., Park, Y., and Kim, S.K. (2022). Alpha-Lipoic Acid Attenuates Apoptosis and Ferroptosis in Cisplatin-Induced Ototoxicity via the Reduction of Intracellular Lipid Droplets. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810981"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"137346","DOI":"10.1016\/j.neulet.2023.137346","article-title":"Alpha lipoic acid ameliorates motor deficits by inhibiting ferroptosis in Parkinson\u2019s disease","volume":"810","author":"Zheng","year":"2023","journal-title":"Neurosci. Lett."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cbin.11505","article-title":"\u03b1-Lipoic acid alleviates ferroptosis in the MPP+ -induced PC12 cells via activating the PI3K\/Akt\/Nrf2 pathway","volume":"45","author":"Liu","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/15376516.2012.730562","article-title":"EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: Review of preliminary findings and risk\/benefit assessment","volume":"23","author":"Born","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jama.2007.26","article-title":"The meaning of translational research and why it matters","volume":"299","author":"Woolf","year":"2008","journal-title":"JAMA"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-publhealth-082214-110901","article-title":"Translating evidence into population health improvement: Strategies and barriers","volume":"36","author":"Woolf","year":"2015","journal-title":"Annu. Rev. Public Health"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J., Kleanthous, M., and Kontoghiorghe, C.N. (2020). The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia. Mediterr. J. Hematol. Infect. Dis., 12.","DOI":"10.4084\/mjhid.2020.011"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2011.043018","article-title":"A pilot trial of deferiprone for neurodegeneration with brain iron accumulation","volume":"96","author":"Abbruzzese","year":"2011","journal-title":"Haematologica"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.parkreldis.2014.03.002","article-title":"Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up","volume":"20","author":"Cossu","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/mds.23751","article-title":"Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial","volume":"26","author":"Zorzi","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.22002","article-title":"Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation","volume":"23","author":"Forni","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.4081\/ni.2017.7279","article-title":"A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients","volume":"9","author":"Rohani","year":"2018","journal-title":"Neurol. Int."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2024). New Insights into Aspirin\u2019s Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites. Antioxidants, 14.","DOI":"10.3390\/antiox14010029"},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2024). The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105150"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"He, Y., Mao, S., Zhao, Y., and Yang, J. (2025). Research Advances in the Synthesis, Metabolism, and Function of Chlorogenic Acid. Foods, 14.","DOI":"10.3390\/foods14111914"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1079\/BJN20061714","article-title":"Absorption and metabolism of caffeic acid and chlorogenic acid in the small intestine of rats","volume":"96","author":"Lafay","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"5572754","DOI":"10.1155\/2023\/5572754","article-title":"The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24\u2212\/\u2212 Progeria Mouse Model","volume":"2023","author":"Hambright","year":"2023","journal-title":"J. Osteoporos."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/20\/3270\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:33:09Z","timestamp":1761021189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/20\/3270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":270,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["nu17203270"],"URL":"https:\/\/doi.org\/10.3390\/nu17203270","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}